| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/2008 | WO2008020085A3 Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy |
| 07/31/2008 | WO2008016793A3 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 07/31/2008 | WO2008008561A3 Attenuation of reperfusion injury |
| 07/31/2008 | WO2008004130A3 Peptides for targeting the mitochondrial transition pore complex for therapeutic apoptosis induction and biological applications |
| 07/31/2008 | WO2007147014A3 Method and systems for using biopolymer-based beads and hydrogels |
| 07/31/2008 | WO2007146126A3 Insulin composition |
| 07/31/2008 | WO2007141533A3 Fkbp-l and uses thereof |
| 07/31/2008 | WO2007136892A3 Engineered antibody-stress protein fusions |
| 07/31/2008 | WO2007127439A3 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| 07/31/2008 | WO2007118077A3 Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis |
| 07/31/2008 | WO2007109244A3 Novel nanoparticles for delivery of active agents |
| 07/31/2008 | WO2007106894A3 Neutralizing agents for bacterial toxins |
| 07/31/2008 | WO2007100640A3 Growth hormone receptor antagonist cancer treatment |
| 07/31/2008 | WO2007082068A3 Methods and compositions for treating asthma in human and non human primates |
| 07/31/2008 | WO2007078633A8 Bacteriocin inducer peptides |
| 07/31/2008 | WO2007067979A3 Targeting vector-phospholipid conjugates |
| 07/31/2008 | WO2007059298A3 Chimeric immunoreceptor useful in treating human cancers |
| 07/31/2008 | WO2001044293A8 Sodium channel proteins |
| 07/31/2008 | US20080183134 kits for inducing rapid bone formation; contains bone anabolic agent and a mechanical alteration device for altering contents of a bone marrow cavity, increase in osteoblast activity; antiresorptive agent for prevent resorption; drug targeting of specific bones |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia |
| 07/31/2008 | US20080182889 Prodrugs of excitatory amino acids |
| 07/31/2008 | US20080182867 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/31/2008 | US20080182814 Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 07/31/2008 | US20080182810 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression |
| 07/31/2008 | US20080182809 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals |
| 07/31/2008 | US20080182808 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides |
| 07/31/2008 | US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080182797 Short peptides comprising the amino acid sequence Cys-Glu-Phe-His as well as analogs and derivatives thereof, which peptides efficiently denitrate cellular proteins and thus prevent tissue damage associated with excess nitric oxide and its reactive species; protection against ischemia/reperfusion injury |
| 07/31/2008 | US20080182796 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/31/2008 | US20080182795 Specific antagonists for glucose-depenent insulinotropic polypeptide (GIP) |
| 07/31/2008 | US20080182794 Methods for treating breast cancer using nrif3 related molecules |
| 07/31/2008 | US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders |
| 07/31/2008 | US20080182792 Diminishing presence of protein aggregates in an environment susceptible to formation of protein aggregate by introducing into environment a compound having two domains, a first domain that binds to protein aggregation having two monomers, and a second domain binding to diminishing protein |
| 07/31/2008 | US20080182791 Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor |
| 07/31/2008 | US20080182790 Nucleic acid encoding protein which has autoinducer inactivation activity; increase disease resistance in plants and animals; capable of efficient inactivation of N-acyl homoserine lactone autoinducers |
| 07/31/2008 | US20080182789 Method of treating pulmonary fibrosis |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182787 Protein isolated from plants (Moringa) or synthesized by recombinant DNA technology; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/31/2008 | US20080182786 Target protein is supported on carrier made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells; clay mineral is preferably a layered clay mineral such as montmorillonite, vermiculite, and illite |
| 07/31/2008 | US20080182785 Protracted Glp-1 Compounds |
| 07/31/2008 | US20080182784 Reduction or mutation in kalirin indicates senile dementia related to diabetes; Alzheimer's disease; inhibiting nitric oxide cytotoxicity |
| 07/31/2008 | US20080182783 Pharmacokinetics; host cell |
| 07/31/2008 | US20080182782 Truncated cytochrome c551 for use as therapeutic agents in prevention and treatment of viral infection and cell proliferative dsorders |
| 07/31/2008 | US20080182781 Process for the Preparation of Peptides |
| 07/31/2008 | US20080182780 Insulin or a peroxisome proliferator-activated receptor (PPAR) agonist |
| 07/31/2008 | US20080182779 Apelin and uses thereof |
| 07/31/2008 | US20080182778 Identification of an Evolutionarily Conserved Pathway Mediating Transrepression of Inflammatory Response Genes by Nuclear Receptors |
| 07/31/2008 | US20080182777 Regulation of cell migration and adhesion |
| 07/31/2008 | US20080182776 Drug-loaded poly (alkyl-cyanoacrylate) nanoparticles and process foe the preparation thereof |
| 07/31/2008 | US20080182775 Administering analogs of luteinizing hormone-releasing hormone, leuprolide; inhibits testosterone secretion |
| 07/31/2008 | US20080182331 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression; DNA gene inactivation construct |
| 07/31/2008 | US20080182329 Methods and products related to metabolic interactions in disease |
| 07/31/2008 | US20080182320 Two-step immunization procedure against chlamydia infection |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080182283 Inhibitors of human plasmin derived from the kunitz domains |
| 07/31/2008 | US20080182236 Within human chromosome 7p15-p14; GPRA polypeptides, nucleic acids, host cells, primers and probes; transgenic animal models; anticarcinogenic agents; chronic obstructive pulmonary disorder; diagnosis; analyzing allelic variation in the locus and GPRA gene |
| 07/31/2008 | US20080181955 Resveratrol amount sufficient to permit release of nitric oxide (NO) during sexual stimulation; polyphenol to inhibit formation of type 5 phosphodiesterase; dry powder derived from grapes that are pressed to remove water; dried and then ground into the dry powder |
| 07/31/2008 | US20080181944 semipermeable walled container that houses a capsule comprising a drug formulation, a piston, and an osmotic composition; releases the drug through a passageway at controlled rate over a sustained release period of time; progestin and estrogen |
| 07/31/2008 | US20080181936 dialdehyde cellulose (DAC) carrier; chemically immobilized blood coagulation factor selected from chitosan and gelatin; bacteriolytic agent selected from the group consisting of a lysozyme enzyme, silver nitrate, and chlorhexidine; chemically immobilized tranexamic acid or epsilon -aminocaproic acid |
| 07/31/2008 | US20080181935 Base-treated, detergent-treated telopeptide collagen and a plurality of stem cells; kit for augmenting, bulking or replacing tissue of a mammal |
| 07/31/2008 | US20080181932 inner core comprising an inert material, the outer layer comprising a plurality of pharmaceutically active agents embedded in a matrix, the matrix being substantially erodable when contacted with an aqueous medium |
| 07/31/2008 | US20080181925 Compositions and Methods for Enzymatic Detachment of Bacterial and Fungal Biofilms |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181917 Methods for therapeutic treatment of carpal tunnel syndrome |
| 07/31/2008 | US20080181915 Cd40 ligand adjuvant for respiratory syncytial virus |
| 07/31/2008 | US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 07/31/2008 | US20080181906 For inducing neutralizing antibodies against HIV; hairpin motif; HIV gp120; hydrogen bonding |
| 07/31/2008 | US20080181904 Contains collagen-like domain and Clq domain; idiotypic antibodies; humanizing; biosynthesis |
| 07/31/2008 | US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia |
| 07/31/2008 | US20080181901 Protein modulator of the plasma membrane Na,K-ATPase |
| 07/31/2008 | US20080181900 Vascular Endothelial Cell Growth Factor Antagonists |
| 07/31/2008 | US20080181898 Wise/sost nucleic acid sequences and amino acid sequences |
| 07/31/2008 | US20080181897 Which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation |
| 07/31/2008 | US20080181896 Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers |
| 07/31/2008 | US20080181895 SP16 protein |
| 07/31/2008 | US20080181894 Tumor/cancer antigens; solid phase synthesis; drug screening |
| 07/31/2008 | US20080181889 antagonist of epithelial membrane protein-2, blocking the entry of Chlamydia into the host cell; biodrug for treating gramnegative bacteria intracellular prokaryotic pathogens; drug screening |
| 07/31/2008 | US20080181886 Polypeptides That Bind Baff And/Or April |
| 07/31/2008 | US20080181885 202P5A5 gene or fragment or its encoded protein, or variants , or a fragment, used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 be used in active or passive immunization; gene therapy, immunotherapy; anticarcinogenic agent biodrug for pancreatic cancer |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | US20080181880 Inducing rapid bone formation; contains bone anabolic agent and a mechanical alteration device for altering contents of a bone marrow cavity, increase in osteoblast activity; antiresorptive agent for prevent resorption; drug targeting of specific bones |
| 07/31/2008 | US20080181879 Fibrin gel for controlled release of tgf-beta and uses thereof |
| 07/31/2008 | US20080181878 composition of thrombin and fibrinogen dimer selected from the group consisting of fibrinogen gamma A/ gamma ' heterodimer and fibrinogen gamma '/ gamma ' homodimer; trauma, plastic, dental, and general surgery, minimally invasive surgery, endoscopy, and microsurgery |
| 07/31/2008 | US20080181877 bioassay of forskolin or phorbol 12-myristate 13-acetate; increase sensitivity of the protein kinase A signalling pathway, increase insulin sensitivity, thermogenesis; obesity, type 2 diabetes, insulin resistance, hypertriglyceridemia, cancer, increase plasma levels of free fatty acids |
| 07/31/2008 | US20080181876 phosphodiesterase (PDE3,4,10,11) inhibitor (Ibudilast, Rolipram, Doxofylline, Roflumilast, Dipyridamole, Cilostazol, Theophylline, Propentofylline) or glial attenuator (Minocycline, interleukin receptor antagonist, MAP-kinase inhibitor) in combination with opioids (Morphine and Oxycodone) |
| 07/31/2008 | US20080181875 being overexpressed in transplanted cells, the cyclophilin protein, as antioxydant and peptidyl prolyl cis trans isomerase ligand, remarkably reduces cytotoxicity induced by immunosuppressant cyclosporin A, so that it can greatly improve the success rate in transplantation; myoblast cell line |
| 07/31/2008 | US20080181873 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease |
| 07/31/2008 | US20080181871 Focal calcium channel modulation |
| 07/31/2008 | US20080181868 Macrocylic oximyl hepatitis c protease inhibitors |
| 07/31/2008 | US20080181867 preparing a pre-concentrate by emulsifying an oil phase castor oil with water and a water soluble pharmaceutically active substance cyclosporine A, then dilute to desired concentration; eye drops for eye disorders; less time and low energy consuming, no negative impact on the chemical stability |
| 07/31/2008 | US20080181866 treating hepatitis C virus infections; 2-[4-(4-Cyclopropylcarbamoyl-phenyl)-thiazol-2-ylcarbamoyl]-indole-1-carboxylic acid benzyl ester; inhibiting viral and host cell targets in the replication cycle |
| 07/31/2008 | US20080181865 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/31/2008 | US20080181864 Reducing mitochondrial membrane potential in mammalian cell by administering an major histocompatibility complex (MHC) class II HLA-DR (human leukocyte antigen) ligand; control disease by manipulating mitochondrial metabolism; drug screening antitumor drug; treating human breast cancer |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | CA2676609A1 Methods and compositions for treating neuropathies |